Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic mutations that drive disease.
The system predicts how DNA changes disrupt gene regulation across different tissues and cell types.
AlphaGenome can analyse up to one million DNA letters at once.
Researchers trained it on public human and mouse genetics databases.
The tool targets mutations linked to cancer, heart disease, autoimmune disorders, and mental health conditions.
Scientists say it could speed up drug discovery and gene therapy design.
Experts describe AlphaGenome as a major step toward understanding the non-coding genome.
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
Andrew Rogers
Andrew Rogers is a freelance journalist based in the USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Journalism from the University of Florida. Throughout his career, he has contributed to outlets such as The New York Times, CNN, and Reuters. Known for his clear reporting and in-depth analysis, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.
Add A Comment
NY Evening Post delivers powerful stories, breaking news, sports, and culture—bringing bold perspectives and timely updates to keep readers informed, inspired, and connected worldwide.
We’re social. Connect with us:
© 2026 NY Evening Posts. All Rights Reserved.